Orbital blowout fracture with ipsilateral fourth nerve palsy.

M. Ruttum,G. Harris

DOI: https://doi.org/10.1016/0002-9394(85)90816-5

1985-08-01

Abstract:

What problem does this paper attempt to address?

Distorted TCR repertoires define multisystem inflammatory syndrome in children

Amna Malik,Eszter N Tóth,Michelle S Teng,Jacob Hurst,Eleanor Watt,Lauren Wise,Natalie Kent,Jack Bartram,Louis Grandjean,Margarita Dominguez-Villar,Stuart Adams,Nichola Cooper

DOI: https://doi.org/10.1371/journal.pone.0274289

IF: 3.7

2022-10-27

PLoS ONE

Abstract:While the majority of children infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) display mild or no symptoms, rare individuals develop severe disease presenting with multisystem inflammatory syndrome (MIS-C). The reason for variable clinical manifestations is not understood. Here, we carried out TCR sequencing and conducted comparative analyses of TCR repertoires between children with MIS-C (n = 12) and mild (n = 8) COVID-19. We compared these repertoires with unexposed individuals (samples collected pre-COVID-19 pandemic: n = 8) and with the Adaptive Biotechnologies MIRA dataset, which includes over 135,000 high-confidence SARS-CoV-2-specific TCRs. We show that the repertoires of children with MIS-C are characterised by the expansion of TRBV11-2 chains with high junctional and CDR3 diversity. Moreover, the CDR3 sequences of TRBV11-2 clones shift away from SARS-CoV-2 specific T cell clones, resulting in distorted TCR repertoires. In conclusion, our study reports that CDR3-independent expansion of TRBV11-2+ cells, lacking SARS-CoV-2 specificity, defines MIS-C in children.
Polyclonal expansion of TCR Vbeta 21.3+ CD4+ and CD8+ T cells is a hallmark of Multisystem Inflammatory Syndrome in Children

Marion Moreews,Kenz Le Gouge,Samira Khaldi-Plassart,Rémi Pescarmona,Anne-Laure Mathieu,Christophe Malcus,Sophia Djebali,Alicia Bellomo,Olivier Dauwalder,Magali Perret,Marine Villard,Emilie Chopin,Isabelle Rouvet,Francois Vandenesh,Céline Dupieux,Robin Pouyau,Sonia Teyssedre,Margaux Guerder,Tiphaine Louazon,Anne Moulin-Zinsch,Marie Duperril,Hugues Patural,Lisa Giovannini-Chami,Aurélie Portefaix,Behrouz Kassai,Fabienne Venet,Guillaume Monneret,Christine Lombard,Hugues Flodrops,Jean-Marie De Guillebon,Fanny Bajolle,Valérie Launay,Paul Bastard,Shen-Ying Zhang,Valérie Dubois,Olivier Thaunat,Jean-Christophe Richard,Mehdi Mezidi,Omran Allatif,Kahina Saker,Marlène Dreux,Laurent Abel,Jean-Laurent Casanova,Jacqueline Marvel,Sophie Trouillet-Assant,David Klatzmann,Thierry Walzer,Encarnita Mariotti-Ferrandiz,Etienne Javouhey,Alexandre Belot

DOI: https://doi.org/10.1126/sciimmunol.abh1516

2021-05-25

Abstract:Multiple Inflammatory Syndrome in Children (MIS-C) is a delayed and severe complication of SARS-CoV-2 infection that strikes previously healthy children. As MIS-C combines clinical features of Kawasaki disease and Toxic Shock Syndrome (TSS), we aimed to compare the immunological profile of pediatric patients with these different conditions. We analyzed blood cytokine expression, and the T cell repertoire and phenotype in 36 MIS-C cases, which were compared to 16 KD, 58 TSS, and 42 COVID-19 cases. We observed an increase of serum inflammatory cytokines (IL-6, IL-10, IL-18, TNF-α, IFNγ, CD25s, MCP1, IL-1RA) in MIS-C, TSS and KD, contrasting with low expression of HLA-DR in monocytes. We detected a specific expansion of activated T cells expressing the Vβ21.3 T cell receptor β chain variable region in both CD4 and CD8 subsets in 75% of MIS-C patients and not in any patient with TSS, KD, or acute COVID-19; this correlated with the cytokine storm detected. The T cell repertoire returned to baseline within weeks after MIS-C resolution. Vβ21.3+ T cells from MIS-C patients expressed high levels of HLA-DR, CD38 and CX3CR1 but had weak responses to SARS-CoV-2 peptides in vitro. Consistently, the T cell expansion was not associated with specific classical HLA alleles. Thus, our data suggested that MIS-C is characterized by a polyclonal Vβ21.3 T cell expansion not directed against SARS-CoV-2 antigenic peptides, which is not seen in KD, TSS and acute COVID-19.
Deep immune profiling uncovers novel associations with clinical phenotypes of Multisystem Inflammatory Syndrome in Children (MIS-C)

Christopher Redmond,Moses M Kitakule,Aran Son,McKella Sylvester,Keith Sacco,Ottavia Delmonte,Francesco Licciardi,Riccardo Castagnoli,Cecilia Poli,Yasmin Espinoza,Camila Astudillo,Sarah E Weber,Gina A Montealegre Sanchez,Karyl Barron,Mary Magliocco,Kerry Dobbs,Yu Zhang,Helen Matthews,Cihan Oguz,Helen C Su,Luigi D Notarangelo,Pamela A Frischmeyer-Guerrerio,Daniella M Schwartz

DOI: https://doi.org/10.1101/2022.08.31.22279265

2022-09-02

MedRxiv

Abstract:Multisystem Inflammatory Syndrome in Children (MIS-C) is a systemic inflammatory condition that follows SARS-CoV2 infection or exposure in children. Clinical presentations are highly variable and include fever, gastrointestinal (GI) disease, shock, and Kawasaki Disease-like illness (MIS-C/KD). Compared to patients with acute COVID, patients with MIS-C have a distinct immune signature and expansion of TRVB11 expressing T cells. However, the relationship between immunological and clinical phenotypes of MIS-C is unknown. Here, we measured serum biomarkers, TCR repertoire, and SARS-CoV2-specific T cell responses in a cohort of 76 MIS-C patients. Serum biomarkers associated with macrophage and Th1 activation were elevated in patients with shock, consistent with previous reports. Significantly increased SARS-CoV-2-induced IFN-γ, IL-2, and TNF-α production were seen in CD4 + T cells from patients with neurologic involvement and respiratory failure. Diarrhea was associated with a significant reduction in shock-associated serum biomarkers, suggesting a protective effect. TRVB11 usage was highly associated with MIS-C/KD and coronary aneurysms, suggesting a potential biomarker for these manifestations in MIS-C patients. By identifying novel immunologic associations with the different clinical phenotypes of MIS-C, this study provides insights into the clinical heterogeneity of MIS-C. These unique immunophenotypic associations could provide biomarkers to identify patients at risk for severe complications of MIS-C, including shock and MIS-C/KD.
Enhanced CD95 and interleukin 18 signalling accompany T cell receptor Vβ21.3+ activation in multi-inflammatory syndrome in children

Zhenguang Zhang,Iain R L Kean,Lisa M Dratva,John A Clark,Eleni Syrimi,Naeem Khan,Esther Daubney,Deborah White,Lauran O'Neill,Catherine Chisholm,Caroline Payne,Sarah Benkenstein,Klaudia Kupiec,Rachel Galassini,Victoria Wright,Helen Winmill,Ceri Robbins,Katherine Brown,Padmanabhan Ramnarayan,Barnaby Scholefield,Mark Peters,Nigel Klein,Hugh Montgomery,Kerstin B Meyer,Sarah A Teichmann,Clare Bryant,Graham Taylor,Nazima Pathan

DOI: https://doi.org/10.1038/s41467-024-48699-y

2024-05-18

Abstract:Multisystem inflammatory syndrome in children is a post-infectious presentation SARS-CoV-2 associated with expansion of the T cell receptor Vβ21.3+ T-cell subgroup. Here we apply muti-single cell omics to compare the inflammatory process in children with acute respiratory COVID-19 and those presenting with non SARS-CoV-2 infections in children. Here we show that in Multi-Inflammatory Syndrome in Children (MIS-C), the natural killer cell and monocyte population demonstrate heightened CD95 (Fas) and Interleuking 18 receptor expression. Additionally, TCR Vβ21.3+ CD4+ T-cells exhibit skewed differentiation towards T helper 1, 17 and regulatory T cells, with increased expression of the co-stimulation receptors ICOS, CD28 and interleukin 18 receptor. We observe no functional evidence for NLRP3 inflammasome pathway overactivation, though MIS-C monocytes show elevated active caspase 8. This, coupled with raised IL18 mRNA expression in CD16- NK cells on single cell RNA sequencing analysis, suggests interleukin 18 and CD95 signalling may trigger activation of TCR Vβ21.3+ T-cells in MIS-C, driven by increased IL-18 production from activated monocytes and CD16- Natural Killer cells.
TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C

Levi Hoste,Lisa Roels,Leslie Naesens,Victor Bosteels,Stijn Vanhee,Sam Dupont,Cedric Bosteels,Robin Browaeys,Niels Vandamme,Kevin Verstaen,Jana Roels,Karel F.A. Van Damme,Bastiaan Maes,Elisabeth De Leeuw,Jozefien Declercq,Helena Aegerter,Leen Seys,Ursula Smole,Sofie De Prijck,Manon Vanheerswynghels,Karlien Claes,Veronique Debacker,Gert Van Isterdael,Lynn Backers,Kathleen B.M. Claes,Paul Bastard,Emmanuelle Jouanguy,Shen-Ying Zhang,Gilles Mets,Joke Dehoorne,Kristof Vandekerckhove,Petra Schelstraete,Jef Willems,Julie Willekens,Heidi Schaballie,Sabine Van daele,Laure Dierickx,Sara David,Evelyn Dhont,Ann Verrijckt,Annick de Jaeger,Emma Beel,Inge Matthijs,Aurélie Minne,Karin Decaestecker,Jijo John,Thomas E.M. Crijnen,Muriel Koninckx,Joery Verbruggen,Goele Nys,Samira Akhnikh,Koen Vanlede,Annelien Coppens,Joke Thijs,Ilse Ryckaert,Annick Covents,Els L.I.M. Duval,Ann Verschelde,Linde De Keyzer,Tine Van Ackere,Astrid Verbist,Charlotte Daeze,Caroline Becue,Justine De Paepe,Jo Keepers,Bruno Bruylants,Sabine Kuypers,Siel Daelemans,Jutte van der Werff ten Bosch,Gerlant van Berlaer,Alexandra Dreesman,Benoit Florkin,Catherine Heijmans,Jean Papadopoulos,Patrick Stordeur,Sophie Janssens,Rudi Beyaert,Yvan Saeys,Jean-Laurent Casanova,Bart N. Lambrecht,Filomeen Haerynck,Simon J. Tavernier,

DOI: https://doi.org/10.1084/jem.20211381

2021-12-16

Abstract:In rare instances, pediatric SARS-CoV-2 infection results in a novel immunodysregulation syndrome termed multisystem inflammatory syndrome in children (MIS-C). We compared MIS-C immunopathology with severe COVID-19 in adults. MIS-C does not result in pneumocyte damage but is associated with vascular endotheliitis and gastrointestinal epithelial injury. In MIS-C, the cytokine release syndrome is characterized by IFNγ and not type I interferon. Persistence of patrolling monocytes differentiates MIS-C from severe COVID-19, which is dominated by HLA-DRlo classical monocytes. IFNγ levels correlate with granzyme B production in CD16+ NK cells and TIM3 expression on CD38+/HLA-DR+ T cells. Single-cell TCR profiling reveals a skewed TCRβ repertoire enriched for TRBV11-2 and a superantigenic signature in TIM3+/CD38+/HLA-DR+ T cells. Using NicheNet, we confirm IFNγ as a central cytokine in the communication between TIM3+/CD38+/HLA-DR+ T cells, CD16+ NK cells, and patrolling monocytes. Normalization of IFNγ, loss of TIM3, quiescence of CD16+ NK cells, and contraction of patrolling monocytes upon clinical resolution highlight their potential role in MIS-C immunopathogenesis.

immunology,medicine, research & experimental
Structural factors involved in the control of metabolism in ascites-tumor cells.

L. Packer,R. H. Golder

DOI: https://doi.org/10.1016/0006-3002(59)90589-X

Biochimica et Biophysica Acta

Abstract:
A genetically modulated Toll-like-receptor-tolerant phenotype in peripheral blood cells of children with multisystem inflammatory syndrome

Rehan Khan,Weizhen Ji,Jeisac Guzman-Rivera,Abhilasha Madhvi,Tracy Andrews,Benjamin Richlin,Christian Suarez,Sunanda Gaur,William Cuddy,Aalok R. Singh,Hulya Bukulmez,David Kaelber,Yukiko Kimura,Usha Ganapathi,Ioannis E. Michailidis,Rahul Ukey,Sandra Moroso-Fela,John K. Kuster,Myriam Casseus,Jason Roy,Lawrence C. Kleinman,Daniel B. Horton,Saquib A. Lakhani,Maria Laura Gennaro

DOI: https://doi.org/10.1101/2024.02.02.24301686

2024-02-05

Abstract:Dysregulated innate immune responses contribute to multisystem inflammatory syndrome in children (MIS-C), characterized by gastrointestinal, mucocutaneous, and/or cardiovascular injury occurring weeks after SARS-CoV-2 exposure. To investigate innate immune functions in MIS-C, we stimulated peripheral blood cells from MIS-C patients with agonists of Toll-like receptors (TLR), key innate immune response initiators. We found severely dampened cytokine responses and elevated gene expression of negative regulators of TLR signaling. Increased plasma levels of zonulin, a gut leakage marker, were also detected. These effects were also observed in children enrolled months after MIS-C recovery. Moreover, cells from MIS-C children carrying rare genetic variants of lysosomal trafficking regulator ( ) were less refractory to TLR stimulation and exhibited lysosomal and mitochondrial abnormalities with altered energy metabolism. Our results strongly suggest that MIS-C hyperinflammation and/or excessive or prolonged stimulation with gut-originated TLR ligands drive immune cells to a lasting refractory state. TLR hyporesponsiveness is likely beneficial, as suggested by excess lymphopenia among rare variant carriers. Our findings point to cellular mechanisms underlying TLR hyporesponsiveness; identify genetic determinants that may explain the MIS-C clinical spectrum; suggest potential associations between innate refractory states and long COVID; and highlight the need to monitor long-term consequences of MIS-C.

Infectious Diseases (except HIV/AIDS)
Molecular mimicry in multisystem inflammatory syndrome in children

Aaron Bodansky,Robert C Mettelman,Joseph J Sabatino Jr,Sara E Vazquez,Janet Chou,Tanya Novak,Kristin L Moffitt,Haleigh S Miller,Andrew F Kung,Elze Rackaityte,Colin R Zamecnik,Jayant V Rajan,Hannah Kortbawi,Caleigh Mandel-Brehm,Anthea Mitchell,Chung-Yu Wang,Aditi Saxena,Kelsey Zorn,David J L Yu,Mikhail V Pogorelyy,Walid Awad,Allison M Kirk,James Asaki,John V Pluvinage,Michael R Wilson,Laura D Zambrano,Angela P Campbell,Overcoming COVID-19 Network Investigators,Paul G Thomas,Adrienne G Randolph,Mark S Anderson,Joseph L DeRisi,Laura L Loftis,Charlotte V Hobbs,Keiko M Tarquinio,Michele Kong,Julie C Fitzgerald,Paula S Espinal,Tracie C Walker,Stephanie P Schwartz,Hillary Crandall,Katherine Irby,Mary Allen Staat,Courtney M Rowan,Jennifer E Schuster,Natasha B Halasa,Shira J Gertz,Elizabeth H Mack,Aline B Maddux,Natalie Z Cvijanovich,Matt S Zinter

DOI: https://doi.org/10.1038/s41586-024-07722-4

IF: 64.8

Nature

Abstract:Multisystem inflammatory syndrome in children (MIS-C) is a severe, post-infectious sequela of SARS-CoV-2 infection1,2, yet the pathophysiological mechanism connecting the infection to the broad inflammatory syndrome remains unknown. Here we leveraged a large set of samples from patients with MIS-C to identify a distinct set of host proteins targeted by patient autoantibodies including a particular autoreactive epitope within SNX8, a protein involved in regulating an antiviral pathway associated with MIS-C pathogenesis. In parallel, we also probed antibody responses from patients with MIS-C to the complete SARS-CoV-2 proteome and found enriched reactivity against a distinct domain of the SARS-CoV-2 nucleocapsid protein. The immunogenic regions of the viral nucleocapsid and host SNX8 proteins bear remarkable sequence similarity. Consequently, we found that many children with anti-SNX8 autoantibodies also have cross-reactive T cells engaging both the SNX8 and the SARS-CoV-2 nucleocapsid protein epitopes. Together, these findings suggest that patients with MIS-C develop a characteristic immune response to the SARS-CoV-2 nucleocapsid protein that is associated with cross-reactivity to the self-protein SNX8, demonstrating a mechanistic link between the infection and the inflammatory syndrome, with implications for better understanding a range of post-infectious autoinflammatory diseases.
Antibody-mediated cellular responses are dysregulated in Multisystem Inflammatory Syndrome in Children (MIS-C)

Jenna K Dick,Jules A Sangala,Venkatramana D Krishna,Aaron Khaimraj,Lydia Hamel,Spencer M Erickson,Dustin Hicks,Yvette Soigner,Laura E Covill,Alexander K Johnson,Michael J Ehrhardt,Keenan Ernste,Petter Brodin,Richard A Koup,Alka Khaitan,Carly Baehr,Beth K Thielen,Christine M Henzler,Caleb Skipper,Jeffrey S Miller,Yenan T Bryceson,Jianming Wu,Chandy C John,Angela Panoskaltsis-Mortari,Alberto Orioles,Marie E Steiner,Maxim C-J Cheeran,Marco Pravetoni,Geoffrey T Hart

DOI: https://doi.org/10.1093/jpids/piae093.025

2024-11-04

Journal of the Pediatric Infectious Diseases Society

Abstract:BackgroundMultisystem Inflammatory Syndrome in Children (MIS-C) is a rare and severe complication of SARS-CoV-2 infection that is characterized by multi-organ involvement and substantial inflammation. The immunological responses in MIS-C are not fully known. Antibody-mediated viral clearance in which innate immune cells interact with antibodies via their Fc receptors to remove the virus is an important mechanism for reducing SARS-CoV-2 viral load. However, little is known about how antibody-mediated cellular responses in MIS-C compared to acute COVID-19 infection and direct testing of cellular function ex vivo to understand the aberrant immune response in MIS-C is limited. Therefore, we focused on the antibody-mediated cellular responses in MIS-C relative to children and adults that had acute COVID-19 infection with spectrum of symptoms. We hypothesized that cells that bind antibodies to help clear the virus are dysfunctional in MIS-C patients, preventing the virus from being fully cleared.MethodsWe collected samples from MIS-C children along with pediatric and adult subjects with a clinical spectrum of COVID-19 symptoms and uninfected controls. Through these controls, we can compare Fc-mediated antibody functions between ages and clinical symptoms. We utilized high dimension flow cytometry to assess phenotype and function of innate immune cells that bind to antibodies and sequencing to study Fc receptor genetic. This data was then correlated with matched clinical data.ResultsMonocytes in MIS-C were hyperfunctional for antibody-dependent cellular phagocytosis and production of proinflammatory cytokines. In contrast, natural killer (NK) cells in MIS-C were hypofunctional for antibody-dependent cellular cytotoxicity and cytokine production. To provide some preliminary insight into mechanism, we show multiple ways leading to decreased cytotoxicity for NK cells, including phenotypic exhaustion of NK cells, variants in CD16 (NK cell Fc receptor) genetics that reduce Fc binding to IgG, and cytokine-induced associations. Using a novel anti-CD16 novel bispecific reagent that we developed, we could rescue the hypofunctional antibody-mediated NK cell function in MIS-C to the same levels as control.ConclusionTogether, our results reveal dysregulation in antibody-mediated responses that are unique to MIS-C and may contribute to the immune pathology of this disease. Specifically, we find that monocytes are hyperfunctional with NK cells are hypofunctional. In the case of the MIS-C antibody-mediated response, while it is likely that multiple pathogenetic mechanisms contribute to MIS-C, our data suggest an imbalance of the antibody-mediated cellular response as a mechanistic correlate of this rare, but life-threatening outcome of SARS-COV-2 in children. Our results highlight that targeted therapies to reduce viral burden and/or boost NK cells responses while decreasing cytokine levels may be effective in preventing MIS-C.

pediatrics,infectious diseases
1093. Multiparametric Investigation Of Spike-Protein Specific T-cell Cytokine Expression Profile In Children With Symptomatic COVID-19 Or Multisystem Inflammatory Syndrome

Filippos Filippatos,Marianna Tzanoudaki,Elizabeth-Barbara Tatsi,Vasiliki Efthymiou,Manolis Liatsis,Vasiliki Syriopoulou,Athanasios Michos

DOI: https://doi.org/10.1093/ofid/ofac492.933

2022-12-01

Open Forum Infectious Diseases

Abstract:Abstract Background Data regarding cell-mediated immunological differences in children across COVID-19 clinical spectrum are limited. We prospectively investigated Spike-protein specific cellular immunity in children with symptomatic COVID-19 or MIS-C, by single cell cytokine expression profiling. Methods PBMCs from children with MIS-C, symptomatic COVID-19 (one month after hospitalization) and healthy controls were isolated prospectively. Cell suspensions were divided into two quantitatively equal samples (a negative control-unstimulated and a positive-stimulated). Cells stimulation was performed using SARS-CoV-2 Spike antigenic peptides mix (Peptivator SARS-CoV-2 Prot_S). Cells of each sample were stained with fluorochrome monoclonal antibodies against 8 surface markers (CD3, CD4, CD8, CD14, CD19, CD137, CD197, CD45RA) and 6 intracellular markers (IL-4, IL-2, IL-17, IFN-γ, TNF-α, Granzyme B). Viability was assessed by 7AAD. Stained cell preparations were analysed using 13 colour Flow Cytometry (DX Flex, Beckman Coulter). Flow cytometric analysis was performed using Kaluza 2.1 Software. Results Sixteen children (4 MIS-C, 8 post-COVID-19 and 4 healthy controls) were included in the study. The mean age (±SD) of the participants was 11.22 years (±3.48). Children with MIS-C had significantly higher mean (±SD) values of CD8+IFN-γ/million CD3+ [226.68 (134.92) vs 45.43 (57.28); P: 0.033] and median (IQR) of CD8+IFN-γ/ml [156.38 (184.13) vs 26.34 (82.36);P: 0.033] compared to symptomatic COVID-19 children. Compared to healthy controls, MIS-C patients had significantly higher median (IQR) values of CD4+IL-2/million CD3+ [923.12 (3777.95) vs 97.59 (71.71); P: 0.042] and CD4+IL-2/ml median (IQR) [626.33 (2744.98) vs 169.3 (173.91); P: 0.042]. No other significant differences were observed regarding other immunological markers in 3 study groups. Conclusion IFN-γ production by CD8+ T cells is highly expressed in children with MIS-C compared to hospitalized children one month after acute COVID-19 and could consist possible immunological biomarker. Further studies are needed in order to elucidate the pathophysiological basis of these findings. Disclosures All Authors: No reported disclosures.

immunology,infectious diseases,microbiology
Real-time field programmable gate array architecture for computer vision

M. Arias-Estrada,C. Torres-Huitzil

DOI: https://doi.org/10.1117/1.1329341

Abstract:This paper presents an architecture for real-time generic convolution of a mask and an image. The architecture is intended for fast low-level image processing. The field programmable gate array (FPGA)-based architecture takes advantage of the availability of registers in FPGAs to implement an efficient and compact module to process the convolutions. The architecture is designed to mini- mize the number of accesses to the image memory and it is based on parallel modules with internal pipeline operation in order to im- prove its performance. The architecture is prototyped in a FPGA, but it can be implemented on dedicated very-large-scale-integrated de- vices to reach higher clock frequencies. Complexity issues, FPGA resources utilization, FPGA limitations, and real-time performance are discussed. Some results are presented and discussed. © 2001
Hemophagocytic Lymphohistiocytosis Gene Variants in Multisystem Inflammatory Syndrome in Children

Anshul Vagrecha,Mingce Zhang,Suchitra Acharya,Shannon Lozinsky,Aaron Singer,Chana Levine,Maha Al-Ghafry,Carolyn Fein Levy,Randy Q. Cron

DOI: https://doi.org/10.3390/biology11030417

2022-03-09

Biology

Abstract:Multisystem inflammatory syndrome in children (MIS-C) affects few children previously infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In 2020, 45 children admitted to our hospital for MIS-C underwent genetic screening with a commercial 109-immune-gene panel. Thirty-nine children were diagnosed with MIS-C, and 25.4% of the 39 MIS-C patients harbored rare heterozygous missense mutations either in primary hemophagocytic lymphohistiocytosis (pHLH) genes (LYST, STXBP2, PRF1, UNC13D, AP3B1) or the HLH-associated gene DOCK8 (four variants). We demonstrate that foamy virus introduction of cDNA for the four DOCK8 variants into human NK-92 natural killer (NK) cells led to decreased CD107a expression (degranulation) and decreased NK cell lytic function in vitro for each variant. Heterozygous carriers of missense mutations in pHLH genes and DOCK8 may serve as risk factors for development of MIS-C among children previously infected with SARS-CoV-2.

biology
[Anti-tumor effect of monkshood polysaccharide with adriamycin long circulating temperature-sensitive liposome and its mechanism].

Lan-feng Dong,Ying-jun Zhang,Jing-sheng Liu,Shu-xia Song,J. Hou,Zhan-jun Lu

2006-07-01

Abstract:AIM To observe the synergic action of monkshood polysaccharide (MPS) and adriamycin (ADM) long circulating temperature-sensitive liposome (ALTSL) in targeting therapy for H22 tumor-bearing mice and explore the mechanism. METHODS The anti-tumor activity was evaluated by using the tumor's weight as an index. The life prolongation rate of mice was calculated according to the survival time of the tumor-bearing mice. The killer activity of NK cells and the lymphocyte transformation rate were detected by the LDH release assay and MTT colorimetry, respectively. The apoptosis of tumor cells and the expressions of p53, Fas, Fas-L and caspase-3 were analyzed by flow cytometry. The expressions of IL-2 mRNA and IL-12 mRNA in spleen lymphocytes were determined by RT-PCR. The pathologic changes of tumor, heart, liver and kidney tissues of the tumor-bearing mice were observed under light microscope. RESULTS Compared with the adriamycin liposome group, the anti-tumor effects were enhanced in (MPS+ALTSL) group with tumor growth inhibitory rate up to 80.4%. The survival time of the tumor-bearing mice in ALTSL and (MPS+ALTSL) groups was significantly prolonged compared with the ADM group (P<0.01). The killer activity of NK cells was higher in ALTSL group than in the NS and ADM groups, and was highest in (MPS+ALTSL) group. The lymphocyte transformation rate of (MPS+ALTSL) group was markedly increased (P<0.01) as compared with the ADM group. The result of RT-PCR indicated that the expressions of IL-2 mRNA and IL-12 mRNA in lymphocytes in the adriamycin long circulating liposome (ALCL) group were significantly higher than those in the ADM group. Expressions of IL-2 mRNA and IL-12 mRNA was much higher in (MPS+ALTSL) group than in ALTSL group. The pathological examination indicated that in (MPS+ALTSL) group, more lymphocytes and monocytes were found in tumor tissue. CONCLUSION ALTSL can increase the anti-tumor effect and decrease the side-effects (such as the cytotoxicity) of ADM. MPS combined with ALTSL can enhance killer activity of NK cells and transformation of T cells, supporting their synergic anti-tumor effect.
Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19

Keith Sacco,Riccardo Castagnoli,Svetlana Vakkilainen,Can Liu,Ottavia M. Delmonte,Cihan Oguz,Ian M. Kaplan,Sara Alehashemi,Peter D. Burbelo,Farzana Bhuyan,Adriana A. de Jesus,Kerry Dobbs,Lindsey B. Rosen,Aristine Cheng,Elana Shaw,Mikko S. Vakkilainen,Francesca Pala,Justin Lack,Yu Zhang,Danielle L. Fink,Vasileios Oikonomou,Andrew L. Snow,Clifton L. Dalgard,Jinguo Chen,Brian A. Sellers,Gina A. Montealegre Sanchez,Karyl Barron,Emma Rey-Jurado,Cecilia Vial,Maria Cecilia Poli,Amelia Licari,Daniela Montagna,Gian Luigi Marseglia,Francesco Licciardi,Ugo Ramenghi,Valentina Discepolo,Andrea Lo Vecchio,Alfredo Guarino,Eli M. Eisenstein,Luisa Imberti,Alessandra Sottini,Andrea Biondi,Sayonara Mató,Dana Gerstbacher,Meng Truong,Michael A. Stack,Mary Magliocco,Marita Bosticardo,Tomoki Kawai,Jeffrey J. Danielson,Tyler Hulett,Manor Askenazi,Shaohui Hu,Jeffrey I. Cohen,Helen C. Su,Douglas B. Kuhns,Michail S. Lionakis,Thomas M. Snyder,Steven M. Holland,Raphaela Goldbach-Mansky,John S. Tsang,Luigi D. Notarangelo,Jason Barnett,Xi Cheng,Krishnaveni Kaladi,Vasudev Kuram,Joseph Mackey,Neha M. Bansal,Andrew J. Martins,Boaz Palterer,Helen Matthews,Uma Mudunuri,Marshall Nambiar,Andrew J. Oler,Andre Rastegar,Smilee Samuel,Conrad Shyu,Varsha Waingankar,Sarah Weber,Sandhya Xirasagar,Yazmin Espinosa,Camila Astudillo,Cecilia Piñera,Ricardo González,Maria De Filippo,Martina Votto,Lorenza Montagna,,,

DOI: https://doi.org/10.1038/s41591-022-01724-3

IF: 82.9

2022-02-17

Nature Medicine

Abstract:Pediatric Coronavirus Disease 2019 (pCOVID-19) is rarely severe; however, a minority of children infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might develop multisystem inflammatory syndrome in children (MIS-C), with substantial morbidity. In this longitudinal multi-institutional study, we applied multi-omics (analysis of soluble biomarkers, proteomics, single-cell gene expression and immune repertoire analysis) to profile children with COVID-19 (n = 110) and MIS-C (n = 76), along with pediatric healthy controls (pHCs; n = 76). pCOVID-19 was characterized by robust type I interferon (IFN) responses, whereas prominent type II IFN-dependent and NF-κB-dependent signatures, matrisome activation and increased levels of circulating spike protein were detected in MIS-C, with no correlation with SARS-CoV-2 PCR status around the time of admission. Transient expansion of TRBV11-2 T cell clonotypes in MIS-C was associated with signatures of inflammation and T cell activation. The association of MIS-C with the combination of HLA A*02, B*35 and C*04 alleles suggests genetic susceptibility. MIS-C B cells showed higher mutation load than pCOVID-19 and pHC. These results identify distinct immunopathological signatures in pCOVID-19 and MIS-C that might help better define the pathophysiology of these disorders and guide therapy.

biochemistry & molecular biology,cell biology,medicine, research & experimental
Myeloid-derived suppressor cells and T cell populations in children with Multisystem Inflammatory Syndrome

Katherine E Bline,Anna L Wilt,Robin N Alexander,Angel N Andrews,Sara E Mertz,Fang Ye,Lisa M Steele,Amber L Wolfe,Asuncion Mejias,Octavio Ramilo

DOI: https://doi.org/10.1038/s41390-023-02919-1

Abstract:Background: Multisystem inflammatory syndrome in children (MIS-C) represents a hyperinflammatory state that can result in multi-organ dysfunction and death. Myeloid-derived suppressor cells (MDSC) are an immunosuppressive cell population that expands under inflammatory conditions and suppresses T cell function. We hypothesized that MDSC would be increased in children with MIS-C and that MDSC expansion would be associated with T cell lymphopenia. Methods: We conducted a prospective, observational study. Initial blood samples were collected within 48 h of admission. Age-matched healthy controls underwent sampling once. MDSC and T cell populations were identified by flow cytometric methods. Results: We enrolled 22 children with MIS-C (12 ICU, 10 ward) and 21 healthy controls (HC). Children with MIS-C demonstrated significantly higher MDSC compared to HC, and MDSC expansion persisted for >3 weeks in the ICU group. Children with MIS-C admitted to the ICU demonstrated significantly lower absolute numbers of T cells and natural killer cells. There were no significant associations between MDSC and cardiac dysfunction, duration of hospitalization, or vasoactive inotrope score. Conclusions: Our study suggests that children critically ill with MIS-C have expansion of MDSC and associated decreased T cell and NK cell populations. Our results did not demonstrate associations between MDSC and clinical outcomes. Impact: Multisystem inflammatory syndrome in children (MIS-C) is a dysregulated immune response occurring several weeks after SARS-CoV-2 infection that can result in multi-organ dysfunction and death. Children severely ill with MIS-C demonstrated increased myeloid-derived suppressor cells and decreased absolute numbers of CD4+ and CD8 + T cells and NK cells compared to healthy controls. There was no significant association between MDSC numbers and clinical outcomes; including cardiac dysfunction, length of stay, or requirement of vasoactive support, in children with MIS-C.
MIS-C: A COVID-19-as sociated condition between hypoimmunity and hyperimmunity

Monica Gelzo,Alice Castaldo,Antonietta Giannattasio,Giulia Scalia,Maddalena Raia,Maria Valeria Esposito,Marco Maglione,Stefania Muzzica,Carolina D'Anna,Michela Grieco,Vincenzo Tipo,Antonio La Cava,Giuseppe Castaldo

DOI: https://doi.org/10.3389/fimmu.2022.985433

2022-10-03

Abstract:Multisystem inflammatory syndrome in children (MIS-C) is a rare, severe complication of COVID-19. A better knowledge of immunological, cellular, and genetic characteristics of MIS-C could help better understand the pathogenesis of the disease and contribute to identifying specific diagnostic biomarkers and develop targeted therapies. We studied 37 MIS-C children at hospital admission and 24 healthy controls analyzing serum cytokines (IFN-α, IFN-β, IFN-γ, IL-6, IL-10, IL-17A, IL-12p70 and TNF), lymphocyte populations by flow cytometry and 386 genes related to autoimmune diseases, autoinflammation and primary immunodeficiencies by NGS. MIS-C patients showed a significant increase of serum IFNγ (despite a significant reduction of activated Th1) and ILs, even if with a great heterogeneity among patients, revealing different pathways involved in MIS-C pathogenesis and suggesting that serum cytokines at admission may help to select the inflammatory pathways to target in each patient. Flow cytometry demonstrated a relevant reduction of T populations while the percentage of B cell was increased in agreement with an autoimmune pathogenesis of MIS-C. Genetic analysis identified variants in 34 genes and 83.3% of patients had at least one gene variant. Among these, 9 were mutated in more patients. Most genes are related to autoimmune diseases like ATM, NCF1, MCM4, FCN3, and DOCK8 or to autoinflammatory diseases associated to the release of IFNγ like PRF1, NOD2, and MEF. Thus, an incomplete clearance of the Sars-CoV2 during the acute phase may induce tissue damage and self-antigen exposure and genetic variants can predispose to hyper-reactive immune dysregulation events of MIS-C-syndrome. Type II IFN activation and cytokine responses (mainly IL-6 and IL-10) may cause a cytokine storm in some patients with a more severe acute phase of the disease, lymphopenia and multisystemic organ involvement. The timely identification of such patients with an immunocytometric panel might be critical for targeted therapeutic management.
Inflammatory and Autoimmune Aspects of Multisystem Inflammatory Syndrome in Children (MIS-C): A Prospective Cohort Study

David A. Lawrence,Aishwarya Jadhav,Tapan K. Mondal,Kyle Carson,William T. Lee,Alexander H. Hogan,Katherine W. Herbst,Ian C. Michelow,Michael Brimacombe,Juan C. Salazar,The Connecticut Children's COVID Collaborative The Connecticut Children's COVID Collaborative

DOI: https://doi.org/10.3390/v16060950

2024-06-13

Viruses

Abstract:Multisystem Inflammatory Syndrome in Children (MIS-C) is a potentially life-threatening complication of COVID-19. The pathophysiological mechanisms leading to severe disease are poorly understood. This study leveraged clinical samples from a well-characterized cohort of children hospitalized with COVID-19 or MIS-C to compare immune-mediated biomarkers. Our objective was to identify selected immune molecules that could explain, in part, why certain SARS-CoV-2-infected children developed MIS-C. We hypothesized that type-2 helper T cell-mediated inflammation can elicit autoantibodies, which may account for some of the differences observed between the moderate–severe COVID-19 (COVID+) and MIS-C cohort. We enumerated blood leukocytes and measured levels of selected serum cytokines, chemokines, antibodies to COVID-19 antigens, and autoantibodies in children presenting to an academic medical center in Connecticut, United States. The neutrophil/lymphocyte and eosinophil/lymphocyte ratios were significantly higher in those in the MIS-C versus COVID+ cohort. IgM and IgA, but not IgG antibodies to SARS-CoV-2 receptor binding domain were significantly higher in the MIS-C cohort than the COVID+ cohort. The serum levels of certain type-2 cytokines (interleukin (IL)-4, IL-5, IL-6, IL-8, IL-10, IL-13, and IL-33) were significantly higher in children with MIS-C compared to the COVID+ and SARS-CoV-2-negative cohorts. IgG autoantibodies to brain antigens and pentraxin were higher in children with MIS-C compared to SARS-CoV-19-negative controls, and children with MIS-C had higher levels of IgG anti-contactin-associated protein-like 2 (caspr2) compared to the COVID+ and SARS-CoV-19-negative controls. We speculate that autoimmune responses in certain COVID-19 patients may induce pathophysiological changes that lead to MIS-C. The triggers of autoimmunity and factors accounting for type-2 inflammation require further investigation.

virology
The identification of a SARs-CoV2 S2 protein-derived peptide with super-antigen-like stimulatory properties on T-cells

Thai Hien Tu,Fatima Ezzahra Bennani,Nasser Masroori,Chen Liu,Atena Nemati,Nicholas Rozza,Amichai Meir Grunbaum,Richard Kremer,Catalin Milhalcioiu,Denis-Claude Roy,Christopher Rudd

DOI: https://doi.org/10.1101/2024.11.26.624714

2024-11-28

Abstract:Severe COVID-19 can trigger a cytokine storm, leading to acute respiratory distress syndrome (ARDS) with similarities to superantigen-induced toxic shock syndrome. An outstanding question is whether SARS-CoV-2 protein sequences can directly induce inflammatory responses. In this study, we identify a region in the SARS-CoV-2 S2 spike protein with sequence homology to bacterial super-antigens (termed P3). Computational modeling predicts P3 binding to sites on MHC class I/II and the TCR that partially overlap with sites for the binding of staphylococcal enterotoxins B and H. Like SEB and SEH peptides, P3 stimulated 25-40% of human CD4+ and CD8+ T cells, increasing IFN-γ and granzyme B production. viSNE and SPADE profiling identified overlapping and distinct IFN-γ and GZMB subsets. The super-antigenic properties of P3 were further evident by its selective expansion of T cells expressing specific TCR Vα and Vβ chain repertoires. In vivo experiments in mice revealed that the administration of P3 led to a significant upregulation of proinflammatory cytokines IL-1β, IL-6, and TNF-α. While the clinical significance of P3 in COVID-19 remains unclear, its homology to other mammalian proteins suggests a potential role for this peptide family in human inflammation and autoimmunity.

Immunology
Emergency myelopoiesis distinguishes multisystem inflammatory syndrome in children from pediatric severe COVID-19

Katerina Roznik,Temesgen E Andargie,T Scott Johnston,Oren Gordon,Yi Wang,Nadine Peart Akindele,Deborah Persaud,Annukka A R Antar,Yukari C Manabe,Weiqiang Zhou,Hongkai Ji,Sean Agbor-Enoh,Andrew H Karaba,Elizabeth A Thompson,Andrea L Cox

DOI: https://doi.org/10.1093/infdis/jiae032

2024-02-02

The Journal of Infectious Diseases

Abstract:Background Multisystem inflammatory syndrome in children (MIS-C) is a hyperinflammatory condition caused by recent SARS-CoV-2 infection, but the underlying immunological mechanisms driving this distinct syndrome are unknown. Methods We utilized high dimensional flow cytometry, cell-free (cf) DNA, and cytokine and chemokine profiling to identify mechanisms of critical illness distinguishing MIS-C from severe acute COVID-19 (SAC). Results Compared to SAC, MIS-C patients demonstrated profound innate immune cell death and features of emergency myelopoiesis (EM), an understudied phenomenon observed in severe inflammation. EM signatures were characterized by fewer mature myeloid cells in the periphery and decreased expression of HLA-DR and CD86 on antigen presenting cells. IL-27, a cytokine known to drive hematopoietic stem cells towards EM, was increased in MIS-C, and correlated with immature cell signatures in MIS-C. Upon recovery, EM signatures decreased, and IL-27 plasma levels returned to normal levels. Despite profound lymphopenia, we report a lack of cfDNA released by adaptive immune cells and increased CCR7 expression on T cells indicative of egress out of peripheral blood. Conclusions Immune cell signatures of EM combined with elevated innate immune cell-derived cfDNA levels distinguish MIS-C from SAC in children and provide mechanistic insight into dysregulated immunity contributing towards MIS-C, offering potential diagnostic and therapeutic targets.

immunology,infectious diseases,microbiology

Orbital blowout fracture with ipsilateral fourth nerve palsy.

Distorted TCR repertoires define multisystem inflammatory syndrome in children

Polyclonal expansion of TCR Vbeta 21.3+ CD4+ and CD8+ T cells is a hallmark of Multisystem Inflammatory Syndrome in Children

Deep immune profiling uncovers novel associations with clinical phenotypes of Multisystem Inflammatory Syndrome in Children (MIS-C)

Enhanced CD95 and interleukin 18 signalling accompany T cell receptor Vβ21.3+ activation in multi-inflammatory syndrome in children

TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C

Structural factors involved in the control of metabolism in ascites-tumor cells.

A genetically modulated Toll-like-receptor-tolerant phenotype in peripheral blood cells of children with multisystem inflammatory syndrome

Molecular mimicry in multisystem inflammatory syndrome in children

Antibody-mediated cellular responses are dysregulated in Multisystem Inflammatory Syndrome in Children (MIS-C)

1093. Multiparametric Investigation Of Spike-Protein Specific T-cell Cytokine Expression Profile In Children With Symptomatic COVID-19 Or Multisystem Inflammatory Syndrome

Real-time field programmable gate array architecture for computer vision

Hemophagocytic Lymphohistiocytosis Gene Variants in Multisystem Inflammatory Syndrome in Children

[Anti-tumor effect of monkshood polysaccharide with adriamycin long circulating temperature-sensitive liposome and its mechanism].

Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19

Myeloid-derived suppressor cells and T cell populations in children with Multisystem Inflammatory Syndrome

MIS-C: A COVID-19-as sociated condition between hypoimmunity and hyperimmunity

Inflammatory and Autoimmune Aspects of Multisystem Inflammatory Syndrome in Children (MIS-C): A Prospective Cohort Study

The identification of a SARs-CoV2 S2 protein-derived peptide with super-antigen-like stimulatory properties on T-cells

Emergency myelopoiesis distinguishes multisystem inflammatory syndrome in children from pediatric severe COVID-19